propafenone has been researched along with 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Chen, H; Gao, X; He, W; Hu, J; Ren, P; Zhu, Y | 1 |
2 other study(ies) available for propafenone and 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
DDPH, a novel antihypertensive agent, is a potential dual inhibitor of hepatic CYP2D and CYP3A.
Topics: Animals; Antihypertensive Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Liver; Male; Phenethylamines; Propafenone; Rats; Rats, Sprague-Dawley | 2016 |